Obesity Hypoventilation Syndrome Prevalence Study

Philips

Status: Terminated

Conditions: Obesity Hypoventilation Syndrome

Treatments: Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.; Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.

Study type: Observational

Funder types: Industry

Identifiers

NCT01964339

HRC-1240-OHSPREV-MS

Details and patient eligibility

About

This is an observational study to characterize the prevalence of Obesity Hypoventilation Syndrome in patients referred to the sleep lab.

Enrollment: 44 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Greater than or equal to 21 yrs. of age
• Referred to sleep lab for diagnostic PSG, initial titration PSG or split night PSG as routine clinical care
• BMI greater than or equal to 30kg/m2

Exclusion criteria

• Acutely ill or medically unstable to participate per PI
• Current positive airway pressure(PAP therapy)users
• Medical History of Chronic Obstructive Pulmonary Disease(COPD)
• Incapable of providing own informed consent
• BMI less than 30kg/m2

Trial design

44 participants in 2 patient groups

BMI greater than or equal to 30kg/m2 -venous

Description:

BMI greater than or equal to 30kg/m2 scheduled for PSG as part of routine clinical care. Participants will undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.

Treatment:

Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.

BMI greater than or equal to 30kg/m2 - arterial

Description:

BMI greater than or equal to 30kg/m2 scheduled for PSG as part of routine clinical care. Participants will undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.

Treatment:

Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.